ATE83008T1 - Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren. - Google Patents
Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren.Info
- Publication number
- ATE83008T1 ATE83008T1 AT88111596T AT88111596T ATE83008T1 AT E83008 T1 ATE83008 T1 AT E83008T1 AT 88111596 T AT88111596 T AT 88111596T AT 88111596 T AT88111596 T AT 88111596T AT E83008 T1 ATE83008 T1 AT E83008T1
- Authority
- AT
- Austria
- Prior art keywords
- viable
- viral vectors
- processes
- production
- animal cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16751—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7714587A | 1987-07-21 | 1987-07-21 | |
EP88111596A EP0300422B1 (de) | 1987-07-21 | 1988-07-19 | Verfahren für die Herstellung von in tierischen Zellen stabilen und lebensfähigen rekombinanten viralen Vektoren |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE83008T1 true ATE83008T1 (de) | 1992-12-15 |
Family
ID=22136338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88111596T ATE83008T1 (de) | 1987-07-21 | 1988-07-19 | Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0300422B1 (de) |
JP (1) | JPH01112986A (de) |
KR (1) | KR890002404A (de) |
AT (1) | ATE83008T1 (de) |
AU (1) | AU610608B2 (de) |
DE (1) | DE3876327D1 (de) |
DK (1) | DK405288A (de) |
IL (1) | IL87170A0 (de) |
NZ (1) | NZ225470A (de) |
ZA (1) | ZA885250B (de) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569679B1 (en) | 1988-03-21 | 2003-05-27 | Chiron Corporation | Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene |
US6133029A (en) * | 1988-03-21 | 2000-10-17 | Chiron Corporation | Replication defective viral vectors for infecting human cells |
US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
US5997859A (en) * | 1988-03-21 | 1999-12-07 | Chiron Corporation | Method for treating a metastatic carcinoma using a conditionally lethal gene |
DE69032841T2 (de) * | 1989-01-23 | 1999-05-12 | Chiron Corp | Rekombinante zellen für therapien von infektionen und hyperprolieferative störungen und deren herstellung |
EP1001032A3 (de) * | 1989-08-18 | 2005-02-23 | Chiron Corporation | Rekombinante Retroviren um Vektorkonstruktionen an Zielzellen zu liefern |
DE69033911D1 (de) * | 1989-10-24 | 2002-03-14 | Chiron Corp | System zur freisetzung von infektiösen proteinen |
US5849572A (en) * | 1990-10-10 | 1998-12-15 | Regents Of The University Of Michigan | HSV-1 vector containing a lat promoter |
US5849571A (en) * | 1990-10-10 | 1998-12-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Latency active herpes virus promoters and their use |
US6120764A (en) * | 1993-06-24 | 2000-09-19 | Advec, Inc. | Adenoviruses for control of gene expression |
US5731172A (en) * | 1994-03-09 | 1998-03-24 | Sumitomo Pharmaceuticals Company, Ltd. | Recombinant adenovirus and process for producing the same |
US5888814A (en) * | 1994-06-06 | 1999-03-30 | Chiron Corporation | Recombinant host cells encoding TNF proteins |
JP4216350B2 (ja) * | 1994-09-19 | 2009-01-28 | 大日本住友製薬株式会社 | 動物細胞感染用の組換えdnaウイルスベクター |
US6825012B2 (en) | 1995-02-23 | 2004-11-30 | Gencell S.A. | DNA molecules, preparation and use in gene therapy |
FR2731014B1 (fr) * | 1995-02-23 | 1997-03-28 | Rhone Poulenc Rorer Sa | Molecules d'adn, preparation et utilisation en therapie genique |
JP3770333B2 (ja) * | 1995-03-15 | 2006-04-26 | 大日本住友製薬株式会社 | 組換えdnaウイルスおよびその製造方法 |
US6964861B1 (en) | 1998-11-13 | 2005-11-15 | Invitrogen Corporation | Enhanced in vitro recombinational cloning of using ribosomal proteins |
JP4020429B2 (ja) * | 1995-06-07 | 2007-12-12 | インヴィトロジェン コーポレーション | 操作された組換え部位を使用する組換えクローニング |
US6143557A (en) * | 1995-06-07 | 2000-11-07 | Life Technologies, Inc. | Recombination cloning using engineered recombination sites |
US6974694B2 (en) | 1995-06-07 | 2005-12-13 | Advec, Inc. | Adenoviruses for control of gene expression |
US6720140B1 (en) | 1995-06-07 | 2004-04-13 | Invitrogen Corporation | Recombinational cloning using engineered recombination sites |
FR2737501B1 (fr) * | 1995-07-31 | 1997-10-24 | Transgene Sa | Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants |
AU726724B2 (en) * | 1995-08-07 | 2000-11-16 | Institut Pasteur | Sequence of natural or synthetic retroelements enabling nucleotide sequence insertion into a eukaryotic cell |
FR2737731B1 (fr) * | 1995-08-07 | 1997-10-10 | Pasteur Institut | Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote |
DE19530412A1 (de) * | 1995-08-18 | 1997-02-20 | Harald Von Prof Dr Melchner | Selbst deletierende retrovirale Vektoren für die Gentherapie |
WO1997019181A2 (de) * | 1995-11-24 | 1997-05-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Virusvektor für den transfer stabiler episome |
WO1997032481A1 (en) | 1996-03-07 | 1997-09-12 | The Regents Of The University Of California | Helper-free, totally defective adenovirus for gene therapy |
US6132989A (en) * | 1996-06-03 | 2000-10-17 | University Of Washington | Methods and compositions for enhanced stability of non-adenoviral DNA |
US5928914A (en) * | 1996-06-14 | 1999-07-27 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Methods and compositions for transforming cells |
US6534314B1 (en) | 1996-06-14 | 2003-03-18 | Massachusetts Institute Of Technology | Methods and compositions for transforming cells |
US5851808A (en) | 1997-02-28 | 1998-12-22 | Baylor College Of Medicine | Rapid subcloning using site-specific recombination |
WO1999021977A1 (en) * | 1997-10-24 | 1999-05-06 | Life Technologies, Inc. | Recombinational cloning using nucleic acids having recombination sites |
CN101125873A (zh) * | 1997-10-24 | 2008-02-20 | 茵维特罗根公司 | 利用具重组位点的核酸进行重组克隆 |
WO1999027123A2 (en) * | 1997-11-26 | 1999-06-03 | Board Of Regents, The University Of Texas System | Modified sv40 viral vectors |
EP2119788A1 (de) | 1999-03-02 | 2009-11-18 | Life Technologies Corporation | Zusammensetzungen und Verfahren zur Verwendung beim Rekombinationsklonen von Nukleinsäuren |
US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
EP2287341B1 (de) | 2003-12-01 | 2013-02-13 | Life Technologies Corporation | Rekombinationsstellen enthaltende Nukleinsäuremoleküle und Verfahren zur Verwendung davon |
-
1988
- 1988-07-19 DE DE8888111596T patent/DE3876327D1/de not_active Expired - Lifetime
- 1988-07-19 EP EP88111596A patent/EP0300422B1/de not_active Expired - Lifetime
- 1988-07-19 AT AT88111596T patent/ATE83008T1/de not_active IP Right Cessation
- 1988-07-19 NZ NZ225470A patent/NZ225470A/xx unknown
- 1988-07-20 DK DK405288A patent/DK405288A/da not_active Application Discontinuation
- 1988-07-20 IL IL87170A patent/IL87170A0/xx unknown
- 1988-07-20 ZA ZA885250A patent/ZA885250B/xx unknown
- 1988-07-20 JP JP63179319A patent/JPH01112986A/ja active Pending
- 1988-07-20 AU AU19201/88A patent/AU610608B2/en not_active Ceased
- 1988-07-21 KR KR1019880009106A patent/KR890002404A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR890002404A (ko) | 1989-04-10 |
EP0300422A2 (de) | 1989-01-25 |
DK405288A (da) | 1989-01-22 |
AU610608B2 (en) | 1991-05-23 |
ZA885250B (en) | 1990-03-28 |
DK405288D0 (da) | 1988-07-20 |
DE3876327D1 (de) | 1993-01-14 |
AU1920188A (en) | 1989-01-27 |
IL87170A0 (en) | 1988-12-30 |
EP0300422B1 (de) | 1992-12-02 |
EP0300422A3 (en) | 1990-02-28 |
JPH01112986A (ja) | 1989-05-01 |
NZ225470A (en) | 1990-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE83008T1 (de) | Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren. | |
ATE91714T1 (de) | Transformation von trichoderma. | |
DE3856505D1 (de) | Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen | |
ATE11153T1 (de) | Verbesserte sulfonsaeurehaltige membranen fuer eine elektrolytische zelle. | |
DE3752050D1 (de) | Elektrochemische Zelle | |
AT369929B (de) | Duenne, flexible elektrode und verfahren zu ihrer herstellung und duenne flexible zelle | |
DE3779996D1 (de) | Explosionsgeschuetzte anordnung fuer eine nichtwaesserige elektrochemische zelle und verfahren zu ihrer herstellung. | |
DE69030539D1 (de) | Wachstumsfaktor aus parenchymalen Lebenszellen, dafür kodierendes Gen, Verfahren zur Herstellung dieses Faktors und Transformanten | |
DE3685797D1 (de) | Clausverfahren zur herstellung von schwefel in gegenwart erhoehter sauerstoffmengen. | |
DE69334211D1 (de) | Multidrug resistenz gen | |
DE69408286T2 (de) | Verfahren zur Herstellung von aktivem Kathodenmaterial für Lithium-Sekundärbatterie | |
DE3853023T2 (de) | Produktion von Kallikrein. | |
IT7923414A0 (it) | Processo di produzione di proteine mediante espressione dei geni corrispondenti in batteri e vettori suscettibili d'essere messi in opera in tali processi. | |
DE3887456D1 (de) | Elektrochemische Zelle. | |
DE3852795T2 (de) | Elektrochemische Zelle. | |
DE68914960T2 (de) | Lithium-Primärzelle mit wasserfreiem Elektrolyt und Verfahren zur Herstellung von Mangandioxid dafür. | |
ES2061719T3 (es) | Proceso para la produccion de proteinas. | |
DE3872228D1 (de) | Elektrode fuer die entwicklung von sauerstoff und deren herstellungsverfahren. | |
ATE109827T1 (de) | Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen. | |
SE429091B (sv) | Forfarande for behandling av cellprotein for att reducera halten nukleinsyra i cellerna | |
DE69012168T2 (de) | Nichtwässerige elektrochemische Zelle und Verfahren zu ihrer Herstellung. | |
DE69229519T2 (de) | Verfahren zur Herstellung von Elektrodenverbindungen für Brennstoffzellen mit Festoxidelektrolyten | |
DE3882220D1 (de) | Herstellung von chlordioxyd in einer elektrolytischen zelle. | |
DK145988D0 (da) | Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse | |
DE3851942T2 (de) | Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |